Blueshift Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$334K Buy
3,358
+667
+25% +$87K 0.1% 310
2025
Q4
$327K Buy
+2,691
New +$338K 0.09% 308
2024
Q4
Sell
-4,343
Closed -$682K 509
2024
Q3
$682K Buy
4,343
+537
+14% +$82.7K 0.17% 146
2024
Q2
$573K Buy
+3,806
New +$457K 0.19% 145

Other funds holding TMDX

Blueshift Asset Management's TMDX Position: Q1 2026 in Review

Blueshift Asset Management increased its Transmedics (TMDX) stake by 25% in Q1 2026, buying an estimated $87K and bringing the position to 3,358 shares worth $334K. The position accounts for 0.1% of the portfolio, ranked #310.

Blueshift Asset Management first reported a position in TMDX in Q2 2024 and has held it in 4 quarters since. The position peaked at $682K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Blueshift Asset Management held 3,358 shares of Transmedics worth $334K as of Q1 2026.
  • Blueshift Asset Management bought 667 Transmedics shares in Q1 2026, an estimated $87K.
  • Transmedics made up 0.1% of Blueshift Asset Management's portfolio in Q1 2026, its #310 holding.
  • Blueshift Asset Management first reported a position in Transmedics in Q2 2024 and has held it in 4 quarters since.
  • Blueshift Asset Management's Transmedics position peaked at $682K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Blueshift Asset Management's 13F filing for Q1 2026, filed 14 May 2026.